Published in World J Gastrointest Pharmacol Ther on August 06, 2014
Present state and future challenges in pediatric abdominal pain therapeutics research: Looking beyond the forest. World J Gastrointest Pharmacol Ther (2015) 0.81
Perspectives on the clinical significance of functional pain syndromes in children. J Pain Res (2015) 0.79
Enhanced sympathetic nerve activity induced by neonatal colon inflammation induces gastric hypersensitivity and anxiety-like behavior in adult rats. Am J Physiol Gastrointest Liver Physiol (2016) 0.77
Therapeutic effect of melatonin on pediatric functional dyspepsia: A pilot study. World J Gastrointest Pharmacol Ther (2016) 0.76
Noninflammatory upregulation of nerve growth factor underlies gastric hypersensitivity induced by neonatal colon inflammation. Am J Physiol Regul Integr Comp Physiol (2015) 0.75
Functional Nausea in Children: A Review of the Literature and Need for Diagnostic Criteria. Children (Basel) (2016) 0.75
Functional gastroduodenal disorders. Gastroenterology (2006) 8.51
Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology (2006) 5.73
Recurrent abdominal pains: a field survey of 1,000 school children. Arch Dis Child (1958) 5.49
Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology (1998) 5.34
Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology (1996) 3.22
Abdominal pain and irritable bowel syndrome in adolescents: a community-based study. J Pediatr (1996) 2.73
A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia. Gut (2011) 2.66
The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis. Gastroenterology (2004) 2.59
Contributions of gastric volumes and gastric emptying to meal size and postmeal symptoms in functional dyspepsia. Gastroenterology (2004) 2.48
Functional abdominal pain: further evidence that whole gut is affected. Br Med J (Clin Res Ed) (1982) 2.41
Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev (2006) 2.40
Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology (2001) 2.36
Functional gastrointestinal disorders as a public health problem. Neurogastroenterol Motil (2008) 2.25
The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis. Am J Gastroenterol (2013) 2.21
Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials. Gut (2007) 2.11
Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol (2003) 2.04
Abnormal clearance of exogenous acid and increased acid sensitivity of the proximal duodenum in dyspeptic patients. Gastroenterology (1999) 2.00
Multicenter, randomized, placebo-controlled trial of amitriptyline in children with functional gastrointestinal disorders. Gastroenterology (2009) 1.86
Double-blind placebo-controlled trial of amitriptyline for the treatment of irritable bowel syndrome in adolescents. J Pediatr (2008) 1.77
Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials. Am J Med (2004) 1.72
Differences in gastric mechanosensory function after repeated ramp distensions in non-consulters with dyspepsia and healthy controls. Gut (2000) 1.70
Heightened visceral sensation in functional gastrointestinal disease is not site-specific. Evidence for a generalized disorder of gut sensitivity. Dig Dis Sci (1995) 1.69
Relationship between symptoms and ingestion of a meal in functional dyspepsia. Gut (2008) 1.67
Gastric accommodation and emptying in evaluation of patients with upper gastrointestinal symptoms. Clin Gastroenterol Hepatol (2003) 1.66
Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder. Gastroenterology (2001) 1.64
A prospective school-based study of abdominal pain and other common somatic complaints in children. J Pediatr (2008) 1.63
Can symptoms discriminate among those with delayed or normal gastric emptying in dysmotility-like dyspepsia? Am J Gastroenterol (2001) 1.62
Prevalence of uninvestigated dyspepsia 8 years after a large waterborne outbreak of bacterial dysentery: a cohort study. Gastroenterology (2010) 1.58
Dyspepsia in children and adolescents: a prospective study. J Pediatr Gastroenterol Nutr (2000) 1.56
Conceptualization and treatment of chronic abdominal pain in pediatric gastroenterology practice. J Pediatr Gastroenterol Nutr (2010) 1.55
Ambulatory gastrojejunal manometry in severe motility-like dyspepsia: lack of correlation between dysmotility, symptoms, and gastric emptying. Gut (1998) 1.54
STW 5, a phytopharmacon for patients with functional dyspepsia: results of a multicenter, placebo-controlled double-blind study. Am J Gastroenterol (2007) 1.54
Impaired drinking capacity in patients with functional dyspepsia: relationship with proximal stomach function. Gastroenterology (2001) 1.51
Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia. Am J Gastroenterol (2004) 1.50
Assessment of gastric sensorimotor function in paediatric patients with unexplained dyspeptic symptoms and poor weight gain. Neurogastroenterol Motil (2007) 1.50
Metoclopramide: pharmacology and clinical application. Ann Intern Med (1983) 1.49
Impaired accommodation of proximal stomach to a meal in functional dyspepsia. Dig Dis Sci (1996) 1.47
Gastric sensory and motor dysfunction in adolescents with functional dyspepsia. J Pediatr (2005) 1.46
Long-term efficacy of low-dose tricyclic antidepressants for children with functional gastrointestinal disorders. J Pediatr Gastroenterol Nutr (2011) 1.44
Abdominal pain in British young people: associations, impairment and health care use. J Psychosom Res (2012) 1.44
High-frequency gastric electrical stimulation for the treatment of gastroparesis: a meta-analysis. World J Surg (2009) 1.40
Reproducibility of gastric myoelectrical activity and the water load test in patients with dysmotility-like dyspepsia symptoms and in control subjects. J Clin Gastroenterol (2000) 1.40
A million-dollar work-up for abdominal pain: is it worth it? J Pediatr Gastroenterol Nutr (2010) 1.38
Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol (2008) 1.35
A randomized trial of yoga for adolescents with irritable bowel syndrome. Pain Res Manag (2006) 1.35
Systematic review: the economic impact of irritable bowel syndrome. Aliment Pharmacol Ther (2003) 1.34
Association of the predominant symptom with clinical characteristics and pathophysiological mechanisms in functional dyspepsia. Gastroenterology (2006) 1.33
Functional dyspepsia, delayed gastric emptying, and impaired quality of life. Gut (2005) 1.32
Enteric-coated, pH-dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children. J Pediatr (2001) 1.32
Pharmacological basis for the medicinal use of ginger in gastrointestinal disorders. Dig Dis Sci (2005) 1.32
Functional dyspepsia impairs quality of life in the adult population. Aliment Pharmacol Ther (2011) 1.27
Serotonin signaling is altered in irritable bowel syndrome with diarrhea but not in functional dyspepsia in pediatric age patients. Gastroenterology (2010) 1.27
Assessment of colon sensitivity by luminal distension in mice. Nat Protoc (2007) 1.26
Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system. Pharmacol Ther (2011) 1.24
Effects of a serotonin 5-HT(4) receptor antagonist SB-207266 on gastrointestinal motor and sensory function in humans. Gut (2000) 1.23
Citalopram treatment of pediatric recurrent abdominal pain and comorbid internalizing disorders: an exploratory study. J Am Acad Child Adolesc Psychiatry (2004) 1.22
Visceral hyperalgesia in children with functional abdominal pain. J Pediatr (2001) 1.21
Role of duodenal lipid and cholecystokinin A receptors in the pathophysiology of functional dyspepsia. Gut (2001) 1.20
The treatment of functional dyspepsia with red pepper. Aliment Pharmacol Ther (2002) 1.20
Diagnosing functional abdominal pain with the Rome II criteria: parent, child, and clinician agreement. J Pediatr Gastroenterol Nutr (2005) 1.20
Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis. Am J Gastroenterol (2001) 1.16
Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther (2000) 1.15
5-Hydroxytryptamine and human small intestinal motility: effect of inhibiting 5-hydroxytryptamine reuptake. Gut (1994) 1.15
Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Neural and neuro-immune mechanisms of visceral hypersensitivity in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol (2012) 1.14
Lansoprazole 30 mg daily versus ranitidine 150 mg b.d. in the treatment of acid-related dyspepsia in general practice. Aliment Pharmacol Ther (1997) 1.13
Evidence for hypomotility in non-ulcer dyspepsia: a prospective multifactorial study. Gut (1991) 1.09
Abnormal resting brain activity in patients with functional dyspepsia is related to symptom severity. Gastroenterology (2011) 1.08
Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia. Clin Gastroenterol Hepatol (2012) 1.07
Tegaserod treatment for dysmotility-like functional dyspepsia: results of two randomized, controlled trials. Am J Gastroenterol (2008) 1.07
Therapeutic efficacy of acotiamide in patients with functional dyspepsia based on enhanced postprandial gastric accommodation and emptying: randomized controlled study evaluation by real-time ultrasonography. Neurogastroenterol Motil (2012) 1.05
Gastric motor disturbances in patients with idiopathic rapid gastric emptying. Neurogastroenterol Motil (2011) 1.05
Influence of the selective serotonin re-uptake inhibitor, paroxetine, on gastric sensorimotor function in humans. Aliment Pharmacol Ther (2003) 1.04
The water load test: observations from healthy controls and patients with functional dyspepsia. Am J Physiol Gastrointest Liver Physiol (2003) 1.04
Double-blind, placebo-controlled trial of famotidine in children with abdominal pain and dyspepsia: global and quantitative assessment. Dig Dis Sci (2001) 1.04
An epidemiologic study of irritable bowel syndrome in adolescents and children in China: a school-based study. Pediatrics (2005) 1.03
Intolerance to visceral distension in functional dyspepsia or irritable bowel syndrome: an organ specific defect or a pan intestinal dysregulation? Neurogastroenterol Motil (2004) 1.03
Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia. J Gastroenterol Hepatol (2007) 1.03
Influence of motilin on gastric fundus tone and on meal-induced satiety in man: role of cholinergic pathways. Am J Gastroenterol (2006) 1.01
Exposure to severe wartime conditions in early life is associated with an increased risk of irritable bowel syndrome: a population-based cohort study. Am J Gastroenterol (2009) 1.01
Dose finding study of mosapride in functional dyspepsia: a placebo-controlled, randomized study. Aliment Pharmacol Ther (2002) 1.00
Correlations among electrogastrogram, gastric dysmotility, and duodenal dysmotility in patients with functional dyspepsia. J Clin Gastroenterol (2009) 1.00
Influence of erythromycin on gastric emptying and meal related symptoms in functional dyspepsia with delayed gastric emptying. Gut (2005) 0.98
New strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline. Aliment Pharmacol Ther (2005) 0.97
Antral inflammatory cells, gastric emptying, and electrogastrography in pediatric functional dyspepsia. Dig Dis Sci (2008) 0.97
Diagnostic utility of wireless motility capsule in gastrointestinal dysmotility. J Clin Gastroenterol (2011) 0.97
Abnormal regional brain activity during rest and (anticipated) gastric distension in functional dyspepsia and the role of anxiety: a H(2)(15)O-PET study. Am J Gastroenterol (2010) 0.96
Rapid gastric emptying, rather than delayed gastric emptying, might provoke functional dyspepsia. J Gastroenterol Hepatol (2011) 0.96
Somatic complaints in childhood functional abdominal pain are associated with functional gastrointestinal disorders in adolescence and adulthood. J Pediatr Gastroenterol Nutr (2011) 0.96
Audio-recorded guided imagery treatment reduces functional abdominal pain in children: a pilot study. Pediatrics (2009) 0.95
Small bowel homing T cells are associated with symptoms and delayed gastric emptying in functional dyspepsia. Am J Gastroenterol (2011) 0.95
Symptoms and subtypes in pediatric functional dyspepsia: relation to mucosal inflammation and psychological functioning. J Pediatr Gastroenterol Nutr (2010) 0.95
Relationship between symptom pattern, assessed by the PAGI-SYM questionnaire, and gastric sensorimotor dysfunction in functional dyspepsia. Neurogastroenterol Motil (2009) 0.94
Efficacy of the 5-HT1A agonist tandospirone citrate in improving symptoms of patients with functional dyspepsia: a randomized controlled trial. Am J Gastroenterol (2009) 0.93
Efficacy of mitemcinal, a motilin agonist, on gastrointestinal symptoms in patients with symptoms suggesting diabetic gastropathy: a randomized, multi-center, placebo-controlled trial. Aliment Pharmacol Ther (2007) 0.93
H2-receptor antagonists in the treatment of functional (nonulcer) dyspepsia: a meta-analysis of randomized controlled clinical trials. Aliment Pharmacol Ther (2001) 0.93
Gastric emptying and myoelectrical activity in children with nonulcer dyspepsia. Effect of cisapride. Dig Dis Sci (1995) 0.93
Effects of amitriptyline on gastric sensorimotor function and postprandial symptoms in healthy individuals: a randomized, double-blind, placebo-controlled trial. Am J Gastroenterol (2008) 0.92
Impaired accommodation of the proximal stomach in children with recurrent abdominal pain. J Pediatr Gastroenterol Nutr (2000) 0.92
Hypersensitivity for capsaicin in patients with functional dyspepsia. Neurogastroenterol Motil (2007) 0.92